Neurology vol. 99 (7 Supplement 1) | Siidon | Guttmann

Cercador

Neurology vol. 99 (7 Supplement 1)

Volumen:

99

Veure revista:

Any publicació:

2022

En aquest número

Planning for Prevention of Parkinson Disease: Now Is the Time
Autor/s:
Crotty GF, Keavney JL, Alcalay RN, Marek K, Marshall GA, Rosas HD, Schwarzschild MA
Introduction
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/1
Article
Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts.
Autor/s:
Niotis K, West AB, Saunders-Pullman R.
Who to Enroll
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/10
Article
Neuroprotective Trials in REM Sleep Behavior Disorder: The Way Forward Becomes Clearer.
Autor/s:
Postuma RB.
Who to Enroll
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/19
Article
Who to Enroll in Parkinson Disease Prevention Trials? The Case for Composite Prodromal Cohorts.
Autor/s:
Molsberry SA, Hughes KC, Schwarzschild MA, Ascherio A.
Who to Enroll
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/26
Article
What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs.
Autor/s:
Crotty GF, Schwarzschild MA.
What Interventions to Test First
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/34
Article
Lifestyle Interventions for the Prevention of Parkinson Disease: A Recipe for Action.
Autor/s:
Janssen Daalen JM, Schootemeijer S, Richard E, Darweesh SKL, Bloem BR.
What Interventions to Test First
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/42
Article
Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures.
Autor/s:
Mirelman A, Siderowf A, Chahine L.
How to Measure Prevention
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/52
Article
What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
Autor/s:
Seibyl JP, Kuo P.
How to Measure Prevention
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/61
Article
Statistical Considerations in the Design of Clinical Trials Targeting Prodromal Parkinson Disease.
Autor/s:
Macklin EA, Coffey CS, Brumm MC, Seibyl JP.
How to Measure Prevention
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/68
Article
Path to Parkinson Disease Prevention: Conclusion and Outlook.
Autor/s:
Berg D, Crotty GF, Keavney JL, Schwarzschild MA, Simuni T, Tanner C.
Conclusions and Next Steps
Any publicació:
2022
Número de revista:
Neurology vol. 99 (7 Supplement 1)
https://n.neurology.org/content/99/7_Supplement_1/76